<DOC>
	<DOCNO>NCT00965172</DOCNO>
	<brief_summary>The goal clinical research study find Caphosol® ( calcium phosphate ) mouthwash effective baking soda solution prevent treat mucositis , patient sarcoma treat chemotherapy . The safety drug also study . Researchers also want learn way calcium phosphate may affect mucous membrane . The goal clinical research study see Caphosol® ( calcium phosphate ) mouthwash well bake soda solution patient sarcoma treat chemotherapy . Caphosol also study see lessens incidence severity oral mucositis ( painful sore mouth ) .</brief_summary>
	<brief_title>Caphosol Sarcoma Patients With Mucositis</brief_title>
	<detailed_description>Chemotherapy radiation therapy hurt normal cell gastrointestinal tract ( include mouth intestine ) . When happen , cause mucositis ( inflammation line mouth , throat , intestine ) . Researchers want compare effect calcium phosphate baking soda patient risk mucositis . The Study Drugs : Caphosol ( calcium phosphate ) saliva-like liquid design replace chemical pH ( acid ) balance mouth . It use mouth rinse moisten , lubricate , clean mouth , include line mouth , tongue , throat . It also use loosen thick mucous help prevent mucous membrane stick together . Baking soda use standard care prevent treat mucositis . Study Groups : If find eligible take part study , randomly assign ( flip coin ) receive either calcium phosphate mouth rinse bake soda mouth rinse study . There equal chance assign either group . You use mouth rinse 5 time every day . The study staff explain mix rinse . Calcium phosphate store room temperature refrigerate . If low sodium diet , check doctor use calcium phosphate . Baseline Tests : The following test procedure perform receive first dose chemotherapy : - Blood ( 3 teaspoon ) draw routine test . - The mucous membrane mouth check . - You ask complete questionnaire ( 15 minute ) feel . - You give diary start cycle record mouth pain . Study Tests : You need come MD Anderson around Days 10 , 12 , 14 ( depend status mucositis ) chemotherapy cycle . During clinic visit , follow test procedure may perform : - You physical exam , include measurement vital sign weight . - Blood ( 3 teaspoon ) draw routine test . - The mucous membrane mouth check . Also , may mouth throat photograph . - You ask complete questionnaire feel . - When possible , optical imaging procedure also perform day . Length Study Reasons Leaving Study Early : You take part study 18 week ( 4 5 month ) . You take study experience intolerable side effect . End Study Visit : You also end study visit complete 6 cycle study drug , take study reason , choose leave study . During visit , follow test procedure perform : - You physical exam , include measurement vital sign weight . - Blood ( 3 teaspoon ) draw routine test . - The mucous membrane mouth check . - You ask complete questionnaire feel . - You receive phone call nurse last dose study drug follow side effect . This investigational study . Caphosol ( calcium phosphate ) FDA approve commercially available use prevent treat mucositis , relief dry mouth high dose chemotherapy radiation treatment . Up 30 patient take part study . All enrol M. D Anderson .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>1 . Patients sarcoma locally advance , high risk relapse metastatic treatment high dose doxorubicin ( 7590 mg/m^2 ) ifosfamide ( AI ) cisplatin ( AP ) indicate . 2 . Must &gt; 16 &lt; 65 year age . 3 . Females childbearing potential ( define postmenopausal 12 month , previous surgical sterilization ) must negative blood pregnancy test . 4 . Male Females child bear potential must use acceptable method birth control include oral contraceptive , spermicide either condom , diaphragm cervical cap , u intrauterine device ( IUD ) abstinence . 5 . Adequate hematologic ( ANC &gt; 1500/mm^3 , platelet count &gt; 150,000/mm^3 ) , renal ( serum creatinine &lt; 1.5mg/dL ) , hepatic ( serum bilirubin count &lt; 1.5 x normal SGPT &lt; 3 x normal ) function . 6 . Karnofsky Performance Status &gt; /= 80 % 7 . Signed informed consent form . 1 . Pregnant lactating woman . 2 . Patients comorbid condition render patient high risk treatment complication . 3 . Patient uncontrolled angina , congestive heart failure ( New York Heart Association &gt; class II know ejection fraction &lt; 40 % ) , uncontrolled cardiac arrhythmia hypertension , acute myocardial infarction within 3 month 4 . Patient active seizure disorder . ( Patients previous history seizure disorder eligible study , evidence seizure activity , free antiseizure medication previous 5 year . ) 5 . Prior surgery radiotherapy ( RT ) within 2 week study entry . 6 . Psychological , social , familial , geographical reason would prevent schedule visit followup .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Mucositis</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Caphosol</keyword>
	<keyword>Calcium phosphate</keyword>
	<keyword>Sodium Bicarbonate</keyword>
	<keyword>Baking Soda Solution</keyword>
	<keyword>Multi-cycle chemotherapy</keyword>
</DOC>